Clinical Trials Browser

Phase 1 × Melanoma × BCG Vaccine × Clear all

NCT01838200 2022-10-12

Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma

Phase 1 Terminated

5 enrolled 12 charts

Melanoma